Escitalopram/sumatriptanReversible cerebral vasoconstriction syndrome: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1979卷 / 1期

关键词：

D O I：

10.1007/s40278-023-47914-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：187 / 187

相关论文

共 50 条

[41] BupropionReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2021, 1844 (1) : 110 - 110
[42] EtoricoxibReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2015, 1533 (1) : 209 - 209
[43] TocilizumabReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2019, 1752 (1) : 369 - 369
[44] Reversible cerebral vasoconstriction syndrome - case report
Buzatu, M.
Bruninx, G.
Roger, T.
Seeldrayers, P.
Coppens, T.
Jeangette, S.
[J]. JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S132 - S132
[45] PhenylephrineReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2020, 1786 (1) : 137 - 137
[46] DesvenlafaxineReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2018, 1710 (1) : 115 - 115
[47] CabergolineReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2020, 1797 (1) : 60 - 60
[48] PrednisoloneReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2022, 1933 (1) : 376 - 376
[49] FluoxetineReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2021, 1875 (1) : 143 - 143
[50] AripiprazoleReversible cerebral vasoconstriction syndrome: case report
[J]. Reactions Weekly, 2023, 1941 (1) : 74 - 74

← 1 2 3 4 5 →